ulcerative colitis
Conditions
Interventions
Mesalazine Group:Mesalazine sustained release granules
Sponsors
General Hospital of Northern Theater Command
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: (1) Consistent with the diagnosis of ulcerative colitis in Chinese and Western medicine; (2) Age 18-60 years old male or female; (3) No treatment for at least 1 month before enrollment; (4) Colonoscopy was consistent with mild moderate and severe inflammatory manifestations; (5) Pathological examination is consistent with the active stage; (6) Voluntary signing of informed consent.
Exclusion criteria
Exclusion criteria: (1) Pregnant and lactating women; (2) Those who have previously suffered from malignant tumors autoimmune diseases or other genetic diseases; (3) People who have taken hormones immune agents biological agents or long-term use of antibiotics; (4) Those who are allergic or intolerant to the drugs in this study; (5) Patients who cannot withstand colonoscopy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| improved Mayo score; | — |
Secondary
| Measure | Time frame |
|---|---|
| total effective rate;TCM syndrome score; | — |
Countries
China
Contacts
Public ContactGongyang
General Hospital of Northern Theater Command
Outcome results
None listed